当前位置: 首页 > 期刊 > 《时珍国医国药》 > 2007年第3期
编号:11429875
藏药杞鹿温肾胶囊治疗原发性骨质疏松症的临床疗效观察
http://www.100md.com 《时珍国医国药》 2007年第3期
藏药杞鹿温肾胶囊;,骨质疏松;,疗效观察,,藏药杞鹿温肾胶囊;,骨质疏松;,疗效观察,1材料和方法,2结果,3讨论,参考文献:
     摘要:目的对藏药杞鹿温肾胶囊治疗原发性骨质疏松症的疗效及潜在的毒副作用进行临床观察。方法1.5年内分别用藏药杞鹿温肾胶囊和骨疏康治疗原发性骨质疏松症患者各30例,12个月为1个疗程,用药前及用药后12个月分别查血、尿、便常规、肝肾功能及电解质、心电图等,同时用QCT测第2~4腰椎的骨密度(BMD),并对患者的腰背酸痛、腰膝酸软等肾虚症状进行评估。结果藏药杞鹿温肾胶囊治疗组总有效率为82.14% ,骨疏康治疗组总有效率为67.86%。杞鹿温肾胶囊对心、肝、肾无毒副作用,对血常规及电解质无不良影响,且能改善心肌的血液循环。结论藏药杞鹿温肾胶囊是一个耐受性良好、安全有效的治疗原发性骨质疏松症的新药。

    关键词:藏药杞鹿温肾胶囊; 骨质疏松; 疗效观察

    Effects and Potential Side Effects of Qilu Wenshen Capsule as A Novel Candidate for the Treatment of Primary Osteoporosis: A Clinical Trial

    LI Wenhua, TU Zhongmin

    (Tibet Nationalities Instiute, Xianyang 712082, China; Xianyong Center of a City Hospital Xianyang 712000, China)

    Abstract:ObjectiveTo investigate the effects and potential side efects of Qilu Wenshen Capsule as a novel candidate for the treatment of primary Osteoporosis.Methods60 patients with primary osteoporosis were randomly divided into group A and group B.Group A was given Qilu Wenshen Capsule and group B was treated with Gushukang granule for 12 months. Before and after the treatment ......

您现在查看是摘要页,全文长 8760 字符